封面
市场调查报告书
商品编码
1590925

医疗保健受託研究机构市场:按类型、服务分类 - 2025-2030 年全球预测

Healthcare Contract Research Organization Market by Type (Clinical, Drug Discovery, Pre-Clinical), Service (Bio-Statistics, Clinical Monitoring, Data Management) - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年,医疗保健受託研究机构市场价值为568.6亿美元,预计到2024年将达到635.2亿美元,复合年增长率为11.82%,到2030年将达到1243亿美元。

医疗保健受託研究机构(CRO) 市场包括为製药、生物技术和医疗设备产业提供的广泛服务,包括药物发现、临床试验、资料管理、监管合规和上市后监测。由于临床开发的复杂性、成本和持续时间,CRO 至关重要,它使公司能够加快上市时间并优化资源,同时降低财务风险。应用范围从临床前研究到 IV 期试验,最终用途包括製药、生技公司和医疗设备製造商。关键的成长要素包括对创新疗法的需求不断增长推动的临床试验数量的增加、加快药物核准的监管压力以及研发支出的增加。在巨量资料、人工智慧和机器学习进步的推动下,医疗保健的数位转型正在为临床试验效率、病患招募和资料分析等创造新的机会。在临床研究活动活性化和有利的法规环境的推动下,亚太和拉丁美洲等新兴市场显示出巨大潜力。然而,他们面临严格的监管要求、复杂的合约管理和高昂的营运成本等挑战。智慧财产权问题和熟练专业人员的短缺使市场动态更加复杂。为了利用成长机会,CRO 应优先考虑整合尖端数位解决方案,建立策略伙伴关係关係,并专注于罕见疾病和个人化医疗等利基研究领域。创新的目标是透过自动化简化流程并促进以患者为中心的试验设计。儘管市场成长潜力巨大,但市场竞争仍然激烈,需要策略差异化和严格的品质合规性。为了实现可持续的业务成长,在遵守各国监管情况的同时投资全球扩张非常重要。因此,CRO 市场是一个充满挑战和机会的动态组合,需要敏捷性和创新来引领市场。

主要市场统计
基准年[2023] 568.6亿美元
预测年份 [2024] 635.2亿美元
预测年份 [2030] 1,243亿美元
复合年增长率(%) 11.82%

市场动态:针对快速发展的医疗保健受託研究机构市场揭示的关键市场洞察

医疗保健受託研究机构市场正在因供需的动态相互作用而发生转变。透过了解这些不断变化的市场动态,公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险,同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 製药公司外包端到端服务的趋势不断成长
    • 扩大再生医学投资
    • 对专业测试服务的需求不断增长
  • 市场限制因素
    • 熟练专业人员减少
  • 市场机会
    • 生物相似药和生技药品领域的需求不断增加
    • 医疗受託研究机构引进新技术
  • 市场挑战
    • 医疗保健CRO服务的品质问题

波特的五力:驾驭医疗保健受託研究机构市场的策略工具

波特的「五力」框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势,解决弱点并避免潜在的挑战,从而确保更强大的市场地位。

PESTLE分析:了解医疗保健受託研究机构市场的外部影响

外部宏观环境因素在塑造医疗受託研究机构市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素,公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化,并为他们做出积极主动的决策做好准备。

市场占有率分析 了解医疗保健受託研究机构市场的竞争状况

对医疗保健受託研究机构市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势,为供应商提供了製定策略决策所需的洞察力,使他们能够在日益激烈的竞争中占有一席之地。

FPNV 医疗保健受託研究机构市场中的定位矩阵供应商绩效评估

FPNV 定位矩阵是评估医疗保健受託研究机构市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商,从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商,以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议,规划医疗保健受託研究机构市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说,对医疗保健受託研究机构市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标,公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战,利用新的商机,并取得长期成功。

本报告对市场进行了全面分析,涵盖关键重点领域:

1. 市场渗透率:详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓:辨识新兴市场的成长机会,评估现有领域的扩张潜力,并提供未来成长的策略蓝图。

3. 市场多元化:分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报:彻底分析竞争格局,检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新:重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题,以帮助相关人员做出明智的决策:

1.目前的市场规模和未来的成长预测是多少?

2. 哪些产品、区隔市场和地区提供最佳投资机会?

3.塑造市场的主要技术趋势和监管影响是什么?

4.主要厂商的市场占有率和竞争地位如何?

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么?

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 製药公司端到端外包趋势增加
      • 加大再生医学投资
      • 对专业测试服务的需求增加
    • 抑制因素
      • 熟练专业人员减少
    • 机会
      • 生物相似药和生技药品产业的新需求
      • 医疗保健合约研究机构引进新技术
    • 任务
      • 医疗保健CRO服务的品质问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 医疗保健受託研究机构市场:按类型

  • 临床
    • 一期测试服务
    • 二期测试服务
    • 三期测试服务
    • IV期测试服务
  • 药物发现
    • 线索识别
    • 先导药物最适化
    • 目标检验
  • 临床前

第七章 医疗保健受託研究机构市场:依服务分类

  • 生物统计学
  • 临床监测
  • 资料管理
  • 支付给调查员
  • 实验室
  • 医学写作
  • 病人和设施招募
  • 计划管理/临床供应管理
  • 品管/保证
  • 监管/医疗
  • 科技

第八章美洲医疗保健受託研究机构市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太医疗保健受託研究机构市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲的医疗保健受託研究机构市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵,2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Advanced Clinical
  • Charles River Laboratories, Inc.
  • Eurofins Scientific SE
  • ICON plc
  • IQVIA Inc.
  • KCR SA
  • Labcorp Drug Development
  • Medpace, Inc.
  • Parexel International Corporation
  • Pharmaron
  • PPD LLC by Thermo Fisher Scientific Inc.
  • SGS Societe Generale de Surveillance SA
  • Syneos Health
  • Syngene International Limited
  • WuXi AppTec
Product Code: MRR-A339DAEFAF80

The Healthcare Contract Research Organization Market was valued at USD 56.86 billion in 2023, expected to reach USD 63.52 billion in 2024, and is projected to grow at a CAGR of 11.82%, to USD 124.30 billion by 2030.

The healthcare contract research organization (CRO) market encompasses a broad range of services provided to pharmaceutical, biotechnology, and medical device sectors, including drug discovery, clinical trials, data management, regulatory compliance, and post-market surveillance. CROs are indispensable due to the complexity, cost, and duration of clinical development, enabling companies to accelerate time-to-market and optimize resources with reduced financial risk. The application scope spans from preclinical studies to Phase IV trials, while end-use extends to pharmaceuticals, biotechnology firms, and medical device manufacturers. Key growth factors include the rising number of clinical trials driven by increasing demand for innovative therapeutics, regulatory pressure demanding faster drug approvals, and expanding R&D expenditure. The digital transformation of healthcare, fostering advancements in big data, artificial intelligence, and machine learning, presents new opportunities, particularly in enhancing trial efficiency, patient recruitment, and data analytics. Emerging markets, like Asia-Pacific and Latin America, exhibit significant potential, driven by increased clinical research activities and favorable regulatory environments. However, the market faces challenges such as stringent regulatory requirements, complex contract management, and high operational costs. Intellectual property concerns and a shortage of skilled professionals further complicate market dynamics. To capitalize on growth opportunities, CROs should prioritize integration of cutting-edge digital solutions, forge strategic partnerships, and focus on niche research areas such as rare diseases and personalized medicine. Innovation should target streamlining processes through automation and fostering patient-centric trial designs. Despite its growth potential, the market's nature remains competitive, necessitating strategic differentiation and robust quality compliance. Investing in global expansion while ensuring adherence to local regulatory landscapes will be crucial for sustained business growth. Consequently, the CRO market presents a dynamic blend of challenges and opportunities, necessitating agility and innovation for market leadership.

KEY MARKET STATISTICS
Base Year [2023] USD 56.86 billion
Estimated Year [2024] USD 63.52 billion
Forecast Year [2030] USD 124.30 billion
CAGR (%) 11.82%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Healthcare Contract Research Organization Market

The Healthcare Contract Research Organization Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing trend of outsourcing end-to-end services by pharmaceutical companies
    • Growing investments in regenerative medicine
    • Increasing need among specialized testing services
  • Market Restraints
    • Reduced skilled professionals
  • Market Opportunities
    • Emerging demand from biosimilars and biologics sector
    • Incorporation of novel technologies by healthcare contract research organizations
  • Market Challenges
    • Quality issues of healthcare CRO services

Porter's Five Forces: A Strategic Tool for Navigating the Healthcare Contract Research Organization Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Healthcare Contract Research Organization Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Healthcare Contract Research Organization Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Healthcare Contract Research Organization Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Healthcare Contract Research Organization Market

A detailed market share analysis in the Healthcare Contract Research Organization Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Healthcare Contract Research Organization Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Healthcare Contract Research Organization Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Healthcare Contract Research Organization Market

A strategic analysis of the Healthcare Contract Research Organization Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Healthcare Contract Research Organization Market, highlighting leading vendors and their innovative profiles. These include Advanced Clinical, Charles River Laboratories, Inc., Eurofins Scientific SE, ICON plc, IQVIA Inc., KCR S.A., Labcorp Drug Development, Medpace, Inc., Parexel International Corporation, Pharmaron, PPD LLC by Thermo Fisher Scientific Inc., SGS Societe Generale de Surveillance SA, Syneos Health, Syngene International Limited, and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Healthcare Contract Research Organization Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Clinical, Drug Discovery, and Pre-Clinical. The Clinical is further studied across Phase I Trial Services, Phase II Trial Services, Phase III Trial Services, and Phase IV Trial Services. The Drug Discovery is further studied across Lead Identification, Lead Optimization, and Target Validation.
  • Based on Service, market is studied across Bio-Statistics, Clinical Monitoring, Data Management, Investigator Payments, Laboratory, Medical Writing, Patient & Site Recruitment, Project Management/Clinical Supply Management, Quality Management/ Assurance, Regulatory/Medical Affairs, and Technology.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing trend of outsourcing end-to-end services by pharmaceutical companies
      • 5.1.1.2. Growing investments in regenerative medicine
      • 5.1.1.3. Increasing need among specialized testing services
    • 5.1.2. Restraints
      • 5.1.2.1. Reduced skilled professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging demand from biosimilars and biologics sector
      • 5.1.3.2. Incorporation of novel technologies by healthcare contract research organizations
    • 5.1.4. Challenges
      • 5.1.4.1. Quality issues of healthcare CRO services
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Healthcare Contract Research Organization Market, by Type

  • 6.1. Introduction
  • 6.2. Clinical
    • 6.2.1. Phase I Trial Services
    • 6.2.2. Phase II Trial Services
    • 6.2.3. Phase III Trial Services
    • 6.2.4. Phase IV Trial Services
  • 6.3. Drug Discovery
    • 6.3.1. Lead Identification
    • 6.3.2. Lead Optimization
    • 6.3.3. Target Validation
  • 6.4. Pre-Clinical

7. Healthcare Contract Research Organization Market, by Service

  • 7.1. Introduction
  • 7.2. Bio-Statistics
  • 7.3. Clinical Monitoring
  • 7.4. Data Management
  • 7.5. Investigator Payments
  • 7.6. Laboratory
  • 7.7. Medical Writing
  • 7.8. Patient & Site Recruitment
  • 7.9. Project Management/Clinical Supply Management
  • 7.10. Quality Management/ Assurance
  • 7.11. Regulatory/Medical Affairs
  • 7.12. Technology

8. Americas Healthcare Contract Research Organization Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Healthcare Contract Research Organization Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Healthcare Contract Research Organization Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advanced Clinical
  • 2. Charles River Laboratories, Inc.
  • 3. Eurofins Scientific SE
  • 4. ICON plc
  • 5. IQVIA Inc.
  • 6. KCR S.A.
  • 7. Labcorp Drug Development
  • 8. Medpace, Inc.
  • 9. Parexel International Corporation
  • 10. Pharmaron
  • 11. PPD LLC by Thermo Fisher Scientific Inc.
  • 12. SGS Societe Generale de Surveillance SA
  • 13. Syneos Health
  • 14. Syngene International Limited
  • 15. WuXi AppTec

LIST OF FIGURES

  • FIGURE 1. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET RESEARCH PROCESS
  • FIGURE 2. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET DYNAMICS
  • TABLE 7. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE I TRIAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE II TRIAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE III TRIAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE IV TRIAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY LEAD IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PRE-CLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIO-STATISTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY INVESTIGATOR PAYMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY LABORATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY MEDICAL WRITING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PATIENT & SITE RECRUITMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PROJECT MANAGEMENT/CLINICAL SUPPLY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY QUALITY MANAGEMENT/ ASSURANCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY REGULATORY/MEDICAL AFFAIRS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 79. JAPAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 83. MALAYSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. MALAYSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 85. MALAYSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 87. PHILIPPINES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. PHILIPPINES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 89. PHILIPPINES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 90. PHILIPPINES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 91. SINGAPORE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SINGAPORE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 93. SINGAPORE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 94. SINGAPORE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 95. SOUTH KOREA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. SOUTH KOREA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 97. SOUTH KOREA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 98. SOUTH KOREA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 99. TAIWAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. TAIWAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 101. TAIWAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 102. TAIWAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 103. THAILAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. THAILAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 105. THAILAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 106. THAILAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 107. VIETNAM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. VIETNAM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 109. VIETNAM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 110. VIETNAM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 116. DENMARK HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. DENMARK HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 118. DENMARK HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 119. DENMARK HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 120. EGYPT HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. EGYPT HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 122. EGYPT HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 123. EGYPT HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 124. FINLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. FINLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 126. FINLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 127. FINLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 128. FRANCE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. FRANCE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 130. FRANCE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 131. FRANCE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 132. GERMANY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. GERMANY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 134. GERMANY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 135. GERMANY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 136. ISRAEL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. ISRAEL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 138. ISRAEL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 139. ISRAEL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 140. ITALY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. ITALY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 142. ITALY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 143. ITALY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 144. NETHERLANDS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NETHERLANDS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 146. NETHERLANDS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 147. NETHERLANDS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 148. NIGERIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. NIGERIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 150. NIGERIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 151. NIGERIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 152. NORWAY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. NORWAY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 154. NORWAY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 155. NORWAY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 156. POLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. POLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 158. POLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 159. POLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 160. QATAR HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. QATAR HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 162. QATAR HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 163. QATAR HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 164. RUSSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. RUSSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 166. RUSSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 167. RUSSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 168. SAUDI ARABIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SAUDI ARABIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 170. SAUDI ARABIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 171. SAUDI ARABIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 176. SPAIN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SPAIN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 178. SPAIN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 179. SPAIN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 180. SWEDEN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. SWEDEN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 182. SWEDEN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 183. SWEDEN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 184. SWITZERLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. SWITZERLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 186. SWITZERLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 187. SWITZERLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 188. TURKEY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. TURKEY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 190. TURKEY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 191. TURKEY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED ARAB EMIRATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED ARAB EMIRATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED ARAB EMIRATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED ARAB EMIRATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED KINGDOM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED KINGDOM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 198. UNITED KINGDOM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 199. UNITED KINGDOM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 200. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 201. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET, FPNV POSITIONING MATRIX, 2023